PAPER Marques LA, Maada I, de Kanter FJ, Lingeman H, Irth H, Niessen WM, Giera M
SEARCH RESULTS
330907 RESULTS
PAPER Ziyatdinova S, Gurevicius K, Kutchiashvili N, Bolkvadze T, Nissinen J, Tanila H, Pitkänen A
Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels.
Epilepsy Res. 2011 Mar;94(1-2):75-85. PubMed: 21300523PAPER James BD, Boyle PA, Buchman AS, Bennett DA
Relation of late-life social activity with incident disability among community-dwelling older adults.
J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):467-73. PubMed: 21300745PAPER Xu Y, Schnorrer P, Proietto A, Kowalski G, Febbraio MA, Acha-Orbea H, Dickins RA, Villadangos JA
IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression.
J Immunol. 2011 Mar 15;186(6):3666-73. PubMed: 21300820PAPER Gravius A, Laszy J, Pietraszek M, Sághy K, Nagel J, Chambon C, Wegener N, Valastro B, Danysz W, Gyertyán I
Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
Behav Pharmacol. 2011 Apr;22(2):122-35. PubMed: 21301322PAPER Hartlage-Rübsamen M, Morawski M, Waniek A, Jäger C, Zeitschel U, Koch B, Cynis H, Schilling S, Schliebs R, Demuth HU, Rossner S
Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms.
Acta Neuropathol. 2011 Jun;121(6):705-19. PubMed: 21301857PAPER Bai Y, Tohda C, Zhu S, Hattori M, Komatsu K
Active components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid β(25-35)-induced neuritic atrophy in cultured rat cortical neurons.
J Nat Med. 2011 Jul;65(3-4):417-23. PubMed: 21301979PAPER Soria-Urios G, Duque P, García-Moreno JM
[Music and brain: neuroscientific foundations and musical disorders].
Rev Neurol. 2011 Jan 1;52(1):45-55. PubMed: 21246493PAPER Koechlin C
[Memory Bistros to maintain social ties for Alzheimer patients and their carers].
Soins Gerontol. 2010 Nov-Dec;(86):27-8. PubMed: 21298963PAPER Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, Miranda D, Lobaugh NJ, Mulsant BH, Pollock BG, Kennedy JL
The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.
Arch Gen Psychiatry. 2011 Feb;68(2):198-206. PubMed: 21300947PAPER Schjeide BM, Schnack C, Lambert JC, Lill CM, Kirchheiner J, Tumani H, Otto M, Tanzi RE, Lehrach H, Amouyel P, von Arnim CA, Bertram L
The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
Arch Gen Psychiatry. 2011 Feb;68(2):207-13. PubMed: 21300948PAPER Kim SY, Karlawish JH, Kim HM, Wall IF, Bozoki AC, Appelbaum PS
Preservation of the capacity to appoint a proxy decision maker: implications for dementia research.
Arch Gen Psychiatry. 2011 Feb;68(2):214-20. PubMed: 21300949Sarah Ellwood
Robert Moir on Crystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's disease.
COMMENT The study describes an elegant tool for what has been a frustrating problem. Of particular interest to us, this study shows that Aβ dimers have striking structural similarities to the dimeric forms of the antimicrobial peptides human NP2, horseshoe crab t
Helen Cunningham on Miami: Is Human Amyloid Imaging Ready for Clinical Trials?
COMMENT Re: "It is generally accepted that about every fifth person diagnosed as having AD turns out after death not to have had amyloid pathology. If AD is defined by its signature pathology, Feldman said, then these 20 percent of cases should not be called
Current Filters
No filters selected